Pulmatrix, Inc. (NASDAQ:PULM) Short Interest Update

Pulmatrix, Inc. (NASDAQ:PULM) was the target of a significant increase in short interest in November. As of November 15th, there was short interest totalling 411,600 shares, an increase of 5,697.2% from the October 31st total of 7,100 shares. Based on an average trading volume of 420,600 shares, the short-interest ratio is presently 1.0 days. Currently, 11.3% of the company’s stock are short sold.

Analyst Ratings Changes

Separately, StockNews.com began coverage on Pulmatrix in a research note on Tuesday. They set a “hold” rating for the company.

Pulmatrix Trading Up 18.0 %

NASDAQ PULM traded up $1.13 during trading on Wednesday, reaching $7.42. The company’s stock had a trading volume of 365,221 shares, compared to its average volume of 130,793. The stock has a market capitalization of $27.08 million, a PE ratio of -2.80 and a beta of 0.99. Pulmatrix has a 1-year low of $1.55 and a 1-year high of $8.44. The business has a 50-day moving average price of $2.82 and a 200-day moving average price of $2.30.

About Pulmatrix

Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.